Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production

  • Xin Li
  • , Yingnan Dai
  • , Shujun Yan
  • , Yanli Shi
  • , Jingxiu Li
  • , Jinglu Liu
  • , Li Cha
  • , Jianjun Mu

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Objective: Resveratrol, a polyphenol of natural compounds, has beneficial cardiovascular effects, many of which are mediated by nitric oxide (NO). Resveratrol increases intracellular calcium and activates AMPactivated protein kinase (AMPK), all of which could increase NO production. We hypothesized that resveratrol via a calcium-dependent NO production lowers blood pressure (BP) in spontaneously hypertensive rats (SHR). Methods: Acetylcholine (Ach)-induced endothelium-dependent relaxations in rat aortas were examined by organ chamber. Blood pressures were determined by radiotelemetry methods. Results: Incubation of isolated aortas from SHR with resveratrol dramatically improved vasorelaxation induced by Ach. Preincubation of aortas with endothelial NO synthase (eNOS) inhibitor or calcium chelant blunted the effects of resveratrol on Ach-induced relaxation, as wells as NO production and eNOS phosphorylation. In animal studies, administration of resveratrol significantly lowered systemic BP in SHR. Conclusion: Resveratrol increases endothelial NO production to improve endothelial dysfunction and lowers BP in hypertensive rats, which depends on calcium-eNOS activation.

Original languageEnglish
Pages (from-to)287-293
Number of pages7
JournalClinical and Experimental Hypertension
Volume38
Issue number3
DOIs
StatePublished - 2 Apr 2016

Keywords

  • Calcium
  • Endothelial dysfunction
  • ENOS
  • Hypertensive
  • Resveratrol

Fingerprint

Dive into the research topics of 'Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production'. Together they form a unique fingerprint.

Cite this